Reversal of Apixaban Induced Alterations in Hemostasis by Different Coagulation Factor Concentrates: Significance of Studies In Vitro with Circulating Human Blood

Apixaban is a new oral anticoagulant with a specific inhibitory action on FXa. No information is available on the reversal of the antihemostatic action of apixaban in experimental or clinical settings. We have evaluated the effectiveness of different factor concentrates at reversing modifications of...

Descripción completa

Detalles Bibliográficos
Autores principales: Escolar, Gines, Fernandez-Gallego, Victor, Arellano-Rodrigo, Eduardo, Roquer, Jaume, Reverter, Joan Carles, Sanz, Victoria Veronica, Molina, Patricia, Lopez-Vilchez, Irene, Diaz-Ricart, Maribel, Galan, Ana Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823858/
https://www.ncbi.nlm.nih.gov/pubmed/24244342
http://dx.doi.org/10.1371/journal.pone.0078696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823858/
https://www.ncbi.nlm.nih.gov/pubmed/24244342
http://dx.doi.org/10.1371/journal.pone.0078696

Ejemplares similares